Learning Objective
The following learning objectives will be addressed:
OB Hemorrhage Safety Update
- Use of uterontonic agents for uterine atony
- Role of fibrinogen in the diagnosis and management of hemorrhage
- Efficacy and safety of TXA for postpartum bleeding
- Risk factors associated with obstetric hemorrhage
Pediatrics
- PediatricsDescribe the metabolic pathways associated with codeine toxicity.
- Summarize alternatives to codeine in perioperative management of post-tonsillectomy pain.
- Assess the evidence related to the recent FDA warning on anesthetic neurotoxicity
- Explain the consensus statement of the Society for Pediatric Anesthesia responding to the FDA Medwatch.
|